NEWS & EVENTS
Prof. Nikolaos Tentolouris from Laikο General Hospital of Athens, Greece, will present a poster titled “Recombinant human collagen-based flowable matrix for chronic wound management: a case study series”.
EWMA 2020 Virtual
New Vergenix™FG clinical results now published
Study by Iacopi E et al from the University Hospital in Pisa, Italy shows increased healing rate and shortened healing time in patients with post-surgical diabetic foot wounds treated with Vergenix™ FG.
Dr. Eyal Shapira presents Vergenix™FG results and wins the presenter prize at the EWMA 2019
Dr. Eyal Shapira from the department of Plastic Surgery, Assaf Harofeh Medical Center, Israel, wins the first time international presenter prize at the EWMA 2019 conference for his oral presentation on the results from a clinical study conducted with Vergenix™FG .
CollPlant signs a distribution agreement with Green Leaf Pharma
CollPlant is pleased to announce that a distribution agreement for Russia and Ukraine has been executed with Green Leaf Pharma, а dynamically growing company specializing in bio-pharmaceutical development and medical device distribution.
Green Leaf Pharma website
Presenting at the EWMA 2019 conference
CollPlant to exhibit at the 29th Conference of the European Wound Management Association (EWMA), 5-7 June 2019 in Gothenburg, Sweden. Dr. Eyal Shapira from the department of Plastic Surgery, Assaf Harofeh Medical Center, Israel, to present results from a clinical study conducted with Vergenix™FG. Visit us at booth B09:09.
EWMA 2019 website
Vergenix™FG clinical results published in WOUNDS journal
Study published in Wounds Journal shows remarkable wound closure performance with Vergenix™FG in the treatment of chronic wounds with a 94% median wound area reduction.